Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson’s Disease

Figure 1

Change in PDSS-2 total score and domain scores from baseline after 3 months of nightly treatment with rotigotine transdermal patch in the efficacy population (). EOT, end of treatment; SD, standard deviation. versus baseline.